Robotic Companion Care With AI

It sounds like something from the future: robotic companion care enabled by AI. Nevertheless, that’s the pioneering area of research currently being explored by Clearday Inc. As a merger with Viveon Health Acquisition Corporation is announced, it looks like this integrated platform is one step closer to widespread use in residential care for seniors (https://longevity.technology/news/clearday-and-viveon-health-spac-announce-merger-agreement-to-accelerate-innovative-longevity-tech/).

Robotic Companion Care With AI Read More »

Glycans, Biological Age and Menopause

GlycanAge is one of the newest ways to assess your biological age, this time by using glycans to evaluate one of the great bugbears of aging: chronic inflammation. One thing that is important to understand is how aging and biomarkers can vary depending on gender, which includes examining the effects of menopause (https://longevity.technology/news/unlocking-longevity-potential-glycanages-approach-to-longevity-healthspan-and-menopause/). Defining biological

Glycans, Biological Age and Menopause Read More »

Cellular Therapy

Cellular therapies are an important area of research for biotech companies, but it’s not the easiest time to secure investment, and many of these new technologies are a long way from producing their own revenue. At least one company is finding alternative ways to keep income flowing while still pushing forward (https://longevity.technology/news/overcoming-the-perfect-storm-in-regenerative-medicine/). Celularity is an

Cellular Therapy Read More »

Scroll to Top